Business & Investment

Vertex Pharmaceuticals, Moderna, Lennar, Salesforce, etc.

Salesforce sign outside an office building in New York.

Scott Mlyn | CNBC

Check out the companies that make headlines for trading at noon on Wednesday:

Allbirds — Allbirds shares fell more than 13%, despite a rise in earnings from last year, after shoe maker losses increased in the third quarter. Allbirds was the first listed company to report its quarterly financial results.

Renner — Following an upgrade to buy from Hold at Goldman Sachs, Renner’s share rose 4.6%, surpassing other homebuilders. The investment company said Renner’s business strategy should lead to strong growth in 2022.

Vertex Pharmaceuticals — Vertex’s share is 8 after biotechnology companies have announced positive results from their VX-147 candidate drug research in severe hereditary renal impairment and plans to move it to critical development. It has risen by more than%.

Modana — Pharmaceutical company stocks fell 8.6% after appealing and losing a patent decision related to competitor Arbutus Pharma’s drug delivery technology. Arbutus’ share price soared 84%.

Salesforce — The share of software giants Mixed Fourth Quarter Guidance, Obscured better than expected results for the third quarter. Salesforce too Presentation Bret Taylor as new co-CEO with Marc Benioff.

Exxon Mobil — Exxon shares increased 2% after the company Expected to double revenue and cash flow From 2019 levels to 2027, while reducing emissions. The company said it expected to spend $ 30 to $ 35 billion a year before the pandemic, while it plans to spend $ 20 to $ 25 billion a year by 2027.

box — Box, a cloud service company, saw its share price rise by 12% following its quarterly financial results. Box earned $ 224 million in revenue of 22 cents per share, while Refinitv estimates it was $ 218.5 million in revenue of 21 cents per share.

Amberella — Semiconductor company stocks surged 24% following higher-than-expected quarterly reports. Amberella recorded a profit of 57 cents per share, 8 cents above Refinitiv’s estimate. Revenue was $ 92.2 million, but the forecast was $ 90.3 million.

Build-A-Bear Workshop — Teddy bear retailers reported record earnings in the third quarter and confirmed that stock prices rose by more than 30% after raising guidance for the full year. It also approved a share buyback of up to $ 25 million.

— CNBC’s Hannah Miao and Jesse Pound contributed to the report

Vertex Pharmaceuticals, Moderna, Lennar, Salesforce, etc. Vertex Pharmaceuticals, Moderna, Lennar, Salesforce, etc.

Back to top button